UBS initiated coverage of Conagra Brands (CAG) with a Neutral rating and $22 price target The firm believes the company’s organic growth should continue to fall short of its low single digit algorithm over the next couple of years, but notes expectations have recalibrated lower to the point where this is priced in. UBS sees 2% downside to consensus earnings estimates in fiscal 2026, but views Conagra’s broader risk/reward as balanced when considering the shares are already trading at “trough multiples on both an absolute and relative basis.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAG:
- Coinbase, Datadog, Tvardi, CF, Conagra: Trending by Analysts
- Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz
- Tapestry, Datadog upgraded: Wall Street’s top analyst calls
- Conagra Brands downgraded to Underperform at BofA on protein cost headwinds
- Conagra Brands downgraded to Underperform from Neutral at BofA
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue